News & Posts

blog.1.image
upcoming meeting

AntibodyPlus - Bispecific Antibodies and Antibody-Drug Conjugates

Live on 12/15/2024. Register now.

Updated on Oct. 21, 2024
See details
blog.1.image
upcoming webinar

Patients First: Opportunities for Therapeutic Antibodies

Dr. Antonios (Tony) Aliprantis
Dec. 7, 2024, 9 p.m. Live on Zoom

Updated on Nov. 12, 2024
See details
blog.1.image
announcements

Antibody Therapeutics indexed in ESCI

Antibody Therapeutics, the official journal of Chinese Antibody Society, published by Oxford University Press, has been accepted by Clarivate for indexing in the Emerging Sources Citation Index (ESCI).

Posted on Oct. 21, 2024
1 minute read

Read Story
blog.5.image

Partner Conference

Chinese Antibody Society (CAS) is a proud partner of Cambridge Healthtech Institute (CHI), organizer of a series of renowned meetings related to antibody therapeutics

1 minute read

Read Story
blog.5.image

Therapeutic antibody licensing deals in China a 2022 end of year summary

We will continue to provide comprehensive analysis and reports about therapeutic antibody licensing deals between Chinese biopharma and overseas companies. In this third business report on this topic, we focus on licensing deals closed in 2022.

9 minutes read

Read Story
blog.5.image

Antibody Training Course

Embed your knowledge on key antibody concepts, applications and strategies, or upskill the entire team, on Informa Connect Life Science’s most popular course

less than a minute read

Read Story
blog.5.image

Therapeutic Antibody Licensing Deals a 2021 End of Year Summary

Fourty antibody deals were closed at a total value of ~ $14.7 billion in 2021. Twenty two of them were in-licensing deals; eighteen were out-licensing deals.

1 minute read

Read Story
blog.5.image

A Brief Overview of Top Antibody Companies in Canada

Canada ranks fourth in global health and biosciences hubs. Canadian biotech companies are nimble, dynamic, and focused. In this article, we will take a deep dive into some of the m

less than a minute read

Read Story
blog.5.image

Antibody Licensing Deals in China H1 2021 Summary

We are excited to announce that PharmaDJ and the Chinese Antibody Society will collaborate to provide comprehensive analysis and reports about therapeutic antibody licensing deals between Chinese biopharma and overseas companies.

1 minute read

Read Story
blog.5.image

FcRn-Targeted Therapies for Autoimmune Disorders Summit

The digital FcRn-Targeted Therapies for Autoimmune Disorders Summit will be virtually held from 23-25, March 2021

less than a minute read

Read Story
blog.5.image

CHI Meetings

10% off registration fee for CAS members when registering for 2021 CHI Meetings

less than a minute read

Read Story
blog.5.image

Experts Perspective Dr Ira Pastan

Interview with Dr Ira Pastan

12 minutes read

Read Story
blog.5.image

Antibody Engineering & Therapeutics (AET) Collaboration

The Chinese Antibody Society (CAS) and the organizing committee of the Antibody Engineering & Therapeutics (AET) conference have entered into a collaboration

1 minute read

Read Story
blog.5.image

Parternship with Cambridge Healthtech Institute

The Chinese Antibody Society and Cambridge Healthtech Institute Announce Strategic Partnership

2 minutes read

Read Story
Icon